Autoimmune Patient Perspective on the Corporate Reputation of Pharma Companies, 2021-2022: Focus on Innovation and Treatments, COVID-19, & Pricing and Access to Medicines
09 janv. 2023 08h28 HE
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent...
Patient Perspective of the Corporate Reputation of Pharma in 2021-2022: Focus on Chiesi Farmaceutici, AbbVie, Bayer, Eli Lilly, GSK, Merck, Mylan, Novartis, Pfizer, Roche, Sanofi, Teva Among Others
09 janv. 2023 08h23 HE
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups"...
The Corporate Reputation of Pharma Companies in Canada, 2021-2022: AbbVie, Roche, BMS, Sanofi, Pfizer, Merck, Bayer and Amgen Made the Biggest Rises
09 janv. 2023 08h18 HE
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Canada Edition - The Views of 124 Canadian Patient Groups" report has been added...
Corporate Reputation of Global Pharma Companies, 2021-2022: How do Pharma Companies Rank Two years into Covid
09 janv. 2023 07h13 HE
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Global Edition" report has been added to ResearchAndMarkets.com's offering. ...
Corporate Reputation of Pharma Companies in 2021-2022: The Patient Perspective of 520 Cancer Patient Groups - Pfizer Ranked 1st, Roche/Genentech Ranked 2nd and Novartis was 3rd
05 janv. 2023 05h53 HE
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups" report has been added...
Corporate Reputation of the Pharma Companies 2021-2022 Based on 168 HIV/AIDS Patient Groups: AbbVie, BMS, Gilead Sciences, GSK, Janssen, Merck, Mylan, Roche/Genentech, Sandoz, Sanofi, Teva, ViiV
13 déc. 2022 05h28 HE
|
Research and Markets
Dublin, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups" report has been...
The Corporate Reputation of Pharma in 2021-2022: The Views of 303 Rare-Disease Patient Groups on 32 Pharma Companies
09 déc. 2022 07h18 HE
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups" report has...
UK Patient's Perspective on the Corporate Reputation of Pharma, 2021-2022: The Views of 111 Patients Groups Two Years into COVID-19
09 déc. 2022 07h13 HE
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - UK Edition - The Views of 111 Patient Groups" report has been added to ...
Survey of 1,500 Patient Groups on the Pharmaceutical Industry and ESG (Environmental, Social, and Governance) - Rankings of a Company's Effectiveness at Adopting and Communicating their ESG Agendas
09 déc. 2022 07h08 HE
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "Pharma and ESG - The Patient Perspective - The Views of 1,500 Patient Groups" report has been added to ResearchAndMarkets.com's offering. This...
Global Bacteriophage Therapy Market Report 2022: Minimal Drug Toxicity, Self-Replication and Less Side Effects Among Benefits Fueling Adoption
28 nov. 2022 08h43 HE
|
Research and Markets
Dublin, Nov. 28, 2022 (GLOBE NEWSWIRE) -- The "Bacteriophage Therapy Market: Distribution by Therapeutic Area, Route of Administration, and Geography: Industry Trends and Global Forecasts,...